1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Schweimer, K. Hoffmann, S. Friedrich, U. Biesinger, B. Roesch, P. Sticht, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 41 5120 10.1021/BI015986J 11955060 Structural Investigation of the Binding of a Herpesviral Protein to the SH3 Domain of Tyrosine Kinase Lck 2002 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7008.682 PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK SH3 DOMAIN RESIDUES 57-119 1 man polymer TYROSINE-PROTEIN KINASE LCK, P56-LCK no no GSPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKAN GSPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKAN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample INTRACELLULAR 9606 HOMO SAPIENS 511693 ESCHERICHIA COLI BL21 PGEX-4T-2 repository Initial release Version format compliance Version format compliance 1 0 2001-10-22 1 1 2011-05-07 1 2 2011-07-13 STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE,NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVEACTIVITY SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56- LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOTYROSYL PEPTIDE EPQPYEEIPIYL SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PHOSPHOTYROSYL PEPTIDE TEGQPYQPQPA STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE. THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) PDBE Y PDBE 2001-02-22 REL THE ALA TO GLY MUTATION AROSE FROM THE EXPRESSION SYSTEM USED IN WHICH THE N-TERMINAL GST-FUSION PARTNER WAS REMOVED BY THROMBIN CLEAVAGE. THE STRUCTURE WAS DETERMINED USING TRIPLE RESONANCE NMR SPECTROSCOPY ON 13C, 15N LABELED LCK-SH3 DOMAIN LEAST RESTRAINT VIOLATION 100 30 3D 15N-EDITED NOESY 3D 13C-EDITED NOESY 2D 15N-FILTERED NOESY 150 mM 6.4 pH 1 atm 298 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. AB INITIO SIMULATED ANNEALING 1 BRUNGER refinement X-PLOR 3.851 structure solution NMRVIEW structure solution XPLOR 600 Bruker DRX GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A PRO 3 n 3 PRO 3 A LEU 4 n 4 LEU 4 A GLN 5 n 5 GLN 5 A ASP 6 n 6 ASP 6 A ASN 7 n 7 ASN 7 A LEU 8 n 8 LEU 8 A VAL 9 n 9 VAL 9 A ILE 10 n 10 ILE 10 A ALA 11 n 11 ALA 11 A LEU 12 n 12 LEU 12 A HIS 13 n 13 HIS 13 A SER 14 n 14 SER 14 A TYR 15 n 15 TYR 15 A GLU 16 n 16 GLU 16 A PRO 17 n 17 PRO 17 A SER 18 n 18 SER 18 A HIS 19 n 19 HIS 19 A ASP 20 n 20 ASP 20 A GLY 21 n 21 GLY 21 A ASP 22 n 22 ASP 22 A LEU 23 n 23 LEU 23 A GLY 24 n 24 GLY 24 A PHE 25 n 25 PHE 25 A GLU 26 n 26 GLU 26 A LYS 27 n 27 LYS 27 A GLY 28 n 28 GLY 28 A GLU 29 n 29 GLU 29 A GLN 30 n 30 GLN 30 A LEU 31 n 31 LEU 31 A ARG 32 n 32 ARG 32 A ILE 33 n 33 ILE 33 A LEU 34 n 34 LEU 34 A GLU 35 n 35 GLU 35 A GLN 36 n 36 GLN 36 A SER 37 n 37 SER 37 A GLY 38 n 38 GLY 38 A GLU 39 n 39 GLU 39 A TRP 40 n 40 TRP 40 A TRP 41 n 41 TRP 41 A LYS 42 n 42 LYS 42 A ALA 43 n 43 ALA 43 A GLN 44 n 44 GLN 44 A SER 45 n 45 SER 45 A LEU 46 n 46 LEU 46 A THR 47 n 47 THR 47 A THR 48 n 48 THR 48 A GLY 49 n 49 GLY 49 A GLN 50 n 50 GLN 50 A GLU 51 n 51 GLU 51 A GLY 52 n 52 GLY 52 A PHE 53 n 53 PHE 53 A ILE 54 n 54 ILE 54 A PRO 55 n 55 PRO 55 A PHE 56 n 56 PHE 56 A ASN 57 n 57 ASN 57 A PHE 58 n 58 PHE 58 A VAL 59 n 59 VAL 59 A ALA 60 n 60 ALA 60 A LYS 61 n 61 LYS 61 A ALA 62 n 62 ALA 62 A ASN 63 n 63 ASN 63 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 54 A N ILE 54 A O TRP 41 A O TRP 41 A N GLN 44 A N GLN 44 A O ARG 32 A O ARG 32 A N LEU 31 A N LEU 31 A O VAL 9 A O VAL 9 A N ILE 10 A N ILE 10 A O ALA 60 A O ALA 60 1 A A O H ALA GLY 11 28 1.56 1 A A H O LEU PHE 12 58 1.57 2 A A O H ALA GLY 11 28 1.54 2 A A H O LEU PHE 12 58 1.58 2 A A H O LEU LYS 34 42 1.59 3 A A O H ALA GLY 11 28 1.52 3 A A H O ARG GLN 32 44 1.58 3 A A H O LEU PHE 12 58 1.58 3 A A O H TRP ILE 41 54 1.58 4 A A H O LEU PHE 12 58 1.55 4 A A O H ALA GLY 11 28 1.56 5 A A O H ALA GLY 11 28 1.53 5 A A H O ARG GLN 32 44 1.58 5 A A H O LEU PHE 12 58 1.58 6 A A O H ALA GLY 11 28 1.54 7 A A O H ALA GLY 11 28 1.55 8 A A O H ALA GLY 11 28 1.54 8 A A H O LEU PHE 12 58 1.58 8 A A H OE1 GLU GLU 26 29 1.59 9 A A O H ALA GLY 11 28 1.55 9 A A O H TRP ILE 41 54 1.57 9 A A H O ARG GLN 32 44 1.60 10 A A O H ALA GLY 11 28 1.53 11 A A O H ALA GLY 11 28 1.53 11 A A H O LEU PHE 12 58 1.55 11 A A H O ARG GLN 32 44 1.56 12 A A O H ALA GLY 11 28 1.55 12 A A H O LEU PHE 12 58 1.57 13 A A O H ALA GLY 11 28 1.52 13 A A H OE1 GLU GLU 26 29 1.58 13 A A H O LEU PHE 12 58 1.58 13 A A O H ARG GLN 32 44 1.58 13 A A H O LEU LYS 34 42 1.60 14 A A O H ALA GLY 11 28 1.54 15 A A O H ALA GLY 11 28 1.53 15 A A H OE1 GLU GLU 26 29 1.59 16 A A O H ALA GLY 11 28 1.55 16 A A H O LEU PHE 12 58 1.56 16 A A H O LEU LYS 34 42 1.58 16 A A H OE1 GLU GLU 26 29 1.59 17 A A O H ALA GLY 11 28 1.56 17 A A H O ARG GLN 32 44 1.58 17 A A O H TRP ILE 41 54 1.58 18 A A O H ALA GLY 11 28 1.56 18 A A H O LEU PHE 12 58 1.58 18 A A H OE1 GLU GLU 26 29 1.58 19 A A O H ALA GLY 11 28 1.55 19 A A O H TRP ILE 41 54 1.58 20 A A O H ALA GLY 11 28 1.54 20 A A H OE1 GLU GLU 26 29 1.56 20 A A H O LEU LYS 34 42 1.56 20 A A H O LEU PHE 12 58 1.57 21 A A O H ALA GLY 11 28 1.54 21 A A H O LEU PHE 12 58 1.58 22 A A O H ALA GLY 11 28 1.55 23 A A O H ALA GLY 11 28 1.55 24 A A O H ALA GLY 11 28 1.55 24 A A H O LEU PHE 12 58 1.59 24 A A O H ASN ILE 7 33 1.59 25 A A O H ALA GLY 11 28 1.54 25 A A H OE1 GLU GLU 26 29 1.56 25 A A H O LEU PHE 12 58 1.57 26 A A O H ALA GLY 11 28 1.56 26 A A H O ARG GLN 32 44 1.58 27 A A O H ALA GLY 11 28 1.53 27 A A O H TRP ILE 41 54 1.57 27 A A H O LEU PHE 12 58 1.58 28 A A O H ALA GLY 11 28 1.54 28 A A H O LEU PHE 12 58 1.56 29 A A O H ALA GLY 11 28 1.55 30 A A O H ALA GLY 11 28 1.54 30 A A H OE1 GLU GLU 26 29 1.55 30 A A O H TRP ILE 41 54 1.56 1 A ARG 32 0.109 SIDE CHAIN 2 A ARG 32 0.104 SIDE CHAIN 3 A ARG 32 0.228 SIDE CHAIN 4 A ARG 32 0.312 SIDE CHAIN 5 A ARG 32 0.147 SIDE CHAIN 6 A ARG 32 0.236 SIDE CHAIN 7 A ARG 32 0.285 SIDE CHAIN 8 A ARG 32 0.218 SIDE CHAIN 9 A ARG 32 0.204 SIDE CHAIN 10 A ARG 32 0.306 SIDE CHAIN 11 A ARG 32 0.317 SIDE CHAIN 12 A ARG 32 0.165 SIDE CHAIN 13 A ARG 32 0.298 SIDE CHAIN 14 A ARG 32 0.312 SIDE CHAIN 15 A ARG 32 0.317 SIDE CHAIN 16 A ARG 32 0.285 SIDE CHAIN 17 A ARG 32 0.261 SIDE CHAIN 18 A ARG 32 0.318 SIDE CHAIN 20 A ARG 32 0.314 SIDE CHAIN 21 A ARG 32 0.175 SIDE CHAIN 22 A ARG 32 0.166 SIDE CHAIN 23 A ARG 32 0.317 SIDE CHAIN 24 A ARG 32 0.131 SIDE CHAIN 25 A ARG 32 0.150 SIDE CHAIN 26 A ARG 32 0.277 SIDE CHAIN 27 A ARG 32 0.317 SIDE CHAIN 28 A ARG 32 0.114 SIDE CHAIN 30 A ARG 32 0.118 SIDE CHAIN 1 A HIS 19 -128.23 -155.35 1 A PHE 25 -45.57 171.11 2 A PHE 25 -45.32 172.19 3 A PHE 25 -48.46 172.50 4 A PHE 25 -50.26 171.74 4 A GLN 36 -142.09 58.60 4 A PRO 55 -47.16 159.35 5 A PHE 25 -44.78 169.59 6 A PHE 25 -50.14 173.53 7 A HIS 19 -141.02 -158.25 7 A PHE 25 -49.91 171.21 8 A PHE 25 -48.28 168.72 9 A PRO 17 -59.96 91.53 9 A PHE 25 -53.36 174.42 10 A PHE 25 -48.74 175.78 11 A HIS 13 -149.35 -158.95 11 A PHE 25 -50.80 171.60 12 A PHE 25 -47.36 171.88 13 A PHE 25 -48.10 170.21 14 A PHE 25 -50.43 174.44 15 A GLU 16 -110.11 75.28 15 A HIS 19 -140.55 -158.26 15 A PHE 25 -54.20 172.71 16 A PRO 17 -62.99 98.91 16 A PHE 25 -52.94 171.35 16 A GLU 35 -172.72 125.49 16 A GLN 36 -101.87 62.88 17 A LEU 4 55.86 -85.34 17 A PHE 25 -50.76 176.33 18 A PHE 25 -46.64 171.62 19 A PHE 25 -49.29 174.55 19 A ALA 62 -43.45 154.97 20 A PHE 25 -45.31 171.13 20 A GLN 36 -151.09 57.80 21 A PHE 25 -53.39 176.57 22 A GLU 16 -106.90 79.48 22 A PRO 17 -47.45 109.62 22 A PHE 25 -54.76 175.99 23 A PRO 17 -48.55 104.55 23 A PHE 25 -47.34 170.60 23 A GLN 36 -142.25 58.10 23 A PRO 55 -46.37 167.41 23 A ALA 62 49.62 -145.73 24 A PHE 25 -53.67 174.13 25 A GLU 16 -114.07 73.87 25 A PHE 25 -47.07 169.45 25 A ALA 60 -160.26 -41.28 25 A ALA 62 49.18 25.13 26 A HIS 19 -129.13 -159.34 26 A PHE 25 -48.43 173.43 27 A PHE 25 -53.12 173.73 28 A PHE 25 -52.61 175.44 29 A GLU 16 -110.45 77.83 29 A PRO 17 -41.52 98.99 29 A PHE 25 -54.13 174.50 30 A PRO 17 -44.36 96.20 30 A PHE 25 -48.71 172.35 PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK SH3 domain of human Lck tyrosine kinase 1 N N TRANSFERASE TRANSFERASE, SH3 DOMAIN, TYROSINE KINASE, SIGNAL TRANSDUCTION, LCK LCK_HUMAN UNP 1 P06239 57 119 1H92 1 63 P06239 A 1 1 63 1 ALA conflict GLY 1 1H92 A P06239 UNP 57 1 5 anti-parallel anti-parallel anti-parallel anti-parallel A GLU 51 A GLU 51 A PRO 55 A PRO 55 A TRP 40 A TRP 40 A SER 45 A SER 45 A GLN 30 A GLN 30 A ILE 33 A ILE 33 A LEU 8 A LEU 8 A ALA 11 A ALA 11 A VAL 59 A VAL 59 A LYS 61 A LYS 61 1 P 1